| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |